Your browser doesn't support javascript.
loading
In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL.
Laukkanen, S; Grönroos, T; Pölönen, P; Kuusanmäki, H; Mehtonen, J; Cloos, J; Ossenkoppele, G; Gjertsen, B; Øystein, B; Heckman, C; Heinäniemi, M; Kontro, M; Lohi, O.
Afiliación
  • Laukkanen S; Tampere Center for Child Health Research, University of Tampere, and Tampere University Hospital, Tampere, Finland.
  • Grönroos T; Tampere Center for Child Health Research, University of Tampere, and Tampere University Hospital, Tampere, Finland.
  • Pölönen P; Institute of Biomedicine, School of Medicine, University of Eastern Finland, Kuopio, Finland.
  • Kuusanmäki H; Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.
  • Mehtonen J; Institute of Biomedicine, School of Medicine, University of Eastern Finland, Kuopio, Finland.
  • Cloos J; Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, The Netherlands.
  • Ossenkoppele G; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.
  • Gjertsen B; Department of Clinical Science, Hematology Section, University of Bergen, Bergen, Norway.
  • Øystein B; Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway.
  • Heckman C; Department of Clinical Science, Hematology Section, University of Bergen, Bergen, Norway.
  • Heinäniemi M; Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway.
  • Kontro M; Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.
  • Lohi O; Institute of Biomedicine, School of Medicine, University of Eastern Finland, Kuopio, Finland.
Blood Cancer J ; 7(9): e604, 2017 09 08.
Article en En | MEDLINE | ID: mdl-28885610
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células T Precursoras / Dasatinib Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Blood Cancer J Año: 2017 Tipo del documento: Article País de afiliación: Finlandia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células T Precursoras / Dasatinib Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Blood Cancer J Año: 2017 Tipo del documento: Article País de afiliación: Finlandia Pais de publicación: Estados Unidos